Morning Market Losers By: Benzinga via Benzinga December 04, 2014 at 09:52 AM EST Kindred Biosciences (NASDAQ: KIN) shares slipped 31.41% to $6.34 after the company reported that it has decided to stop its Atokin ... Read More >> Related Stocks: ANI Pharma Inc Barnes & Noble Christopher & Banks Corp Express Inc Gildan Activewear Kindred Biosciences Microsoft Sea Change Intl IN